ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,809,564 | -67.8% | 603,188 | -59.9% | 0.00% | -100.0% |
| Q2 2023 | $5,623,026 | +3.8% | 1,503,483 | -7.0% | 0.00% | 0.0% |
| Q1 2023 | $5,414,967 | +63.5% | 1,616,408 | +134.7% | 0.00% | 0.0% |
| Q4 2022 | $3,312,094 | +18.0% | 688,585 | +39.5% | 0.00% | – |
| Q3 2022 | $2,808,000 | -19.9% | 493,504 | -0.1% | 0.00% | – |
| Q2 2022 | $3,506,000 | -73.8% | 493,854 | -73.4% | 0.00% | -100.0% |
| Q1 2022 | $13,407,000 | -32.3% | 1,856,925 | -16.2% | 0.00% | -50.0% |
| Q4 2021 | $19,818,000 | +69.7% | 2,216,832 | +565.8% | 0.00% | +33.3% |
| Q3 2021 | $11,675,000 | +158.2% | 332,982 | +58.2% | 0.00% | +200.0% |
| Q2 2021 | $4,521,000 | +275.2% | 210,481 | +978.6% | 0.00% | – |
| Q1 2021 | $1,205,000 | -82.9% | 19,514 | -88.4% | 0.00% | -100.0% |
| Q4 2020 | $7,028,000 | – | 168,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |